Safety, Tolerability, PK and Efficacy of AZD1152 in Patients With Relapsed Acute Myeloid Leukemia
Clinical trial NCT00497991 · COMPLETED
Trial details
- NCT number
- NCT00497991
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-05-01
- Primary completion
- 2009-10-01
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.